Alvocidib [flavopiridol] may be an effective treatment for patients with refractory chronic lymphocytic leukaemia

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1577, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cladribine may increase the risk of secondary lung cancer in patients with chronic lymphocytic leukaemia (CLL)

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

New Directions in the Diagnosis and Treatment of Chronic Lymphocytic Leukaemia

By Schriever F. Huhn D.

Drugs, Vol. 63, Iss. 10, 2003-01 ,pp. : 953-969

Adis International

Access to resources Recommend Favorite

The novel sulfonylhydrazine alkylating agent VNP 40101M may be a feasible treatment for patients with relapsed or refractory leukaemia

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Management of Chronic Lymphocytic Leukaemia

By Kalil N. Cheson B.D.

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite

Fludarabine in chronic lymphocytic leukaemia

By Elter Thomas Hallek Michael Engert Andreas

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1641-1651

Informa Healthcare

Access to resources Recommend Favorite